Group 1 - The company Shichuang Medical (SZ 300078) faced regulatory action due to its former chairman and general manager, Zhang Lizhong, providing a personal loan guarantee of 76 million RMB without proper disclosure, violating multiple regulations [1] - As a result of Zhang's actions, a lawsuit was filed by creditors in November 2024, leading to the freezing of 57.6625 million RMB in a special fundraising account for a subsidiary [1] - The company reported its revenue composition for the first half of 2025, with real estate sales accounting for 53.84%, business intelligence for 39.28%, and smart healthcare for 6.87% [2] Group 2 - As of the latest report, Shichuang Medical has a market capitalization of 4.9 billion RMB [3]

Group 1 - The company, Sichuang Medical (SZ 300078), announced that its 15th board meeting of the 6th session was held on December 12, 2025, via telecommunication voting, where it reviewed the proposal for expected daily related transactions for 2026 [1] - For the first half of 2025, the company's revenue composition was as follows: real estate sales accounted for 53.84%, business intelligence for 39.28%, and smart healthcare for 6.87% [1] - As of the time of reporting, Sichuang Medical's market capitalization was 4.8 billion yuan [1]

Group 1 - The company, Sichuang Medical, announced its sixth board meeting on October 31, 2025, to discuss the election of independent director candidates and other documents [1] - For the first half of 2025, the revenue composition of Sichuang Medical was as follows: real estate sales accounted for 53.84%, business intelligence for 39.28%, and smart healthcare for 6.87% [1] - As of the report date, Sichuang Medical's market capitalization was 4 billion yuan [1]